HALO logo
halo search icon
AVE
Avecho Biotechnology Limited

AVE · Avecho Biotechnology Limited

0.022

AUD
0.00 (0.00%)
10/08/2026 03:43:38 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$85.00M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 10/08/2026 03:43:38 PM

Price Chart

Description

Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. It operates through the Production and Human Health segments. The Production segment focuses on manufacturing and sale of TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment consists of delivery of pharmaceutical products through gels, injectables and patches including conduct of research and development activities. The company was founded by Mark Gregory Kerr on June 19, 1992 and is headquartered in Clayton, Australia.

  • All-Companies
  • All-Consensus
  • GROWTH AUS
  • HALO Consensus Value
  • HALO Ords

Key Fundamentals

EPS 3 yr Growth

7.70%

EBITDA Margin

-474.00%

Operating Cashflow

$1m

Free Cash Flow Return

45.50%

ROIC

-182.40%

Interest Coverage

-12.70

Quick Ratio

9.90

Performance

52 weeks range

Low 0 - 0.03

Trade Value (12mth)

AU$25,757.00

1 week

15.79%

1 month

0%

YTD

131.58%

1 year

450%

All time high

0.42

Additional Data

Shares Outstanding (Fully Diluted)

3,426m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
03 August 26ASXD
29 July 26ASXD
30 June 26ASXD
24 June 26ASXD
24 June 26ASXD

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
The current share price of Avecho Biotechnology Limited (AVE:ASX) is AUD$0.02.
2
What is the 52-week high share price for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
The 52-week high share price for Avecho Biotechnology Limited (AVE:ASX) is AUD$0.03.
3
What is the 52-week low share price for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
The 52-week low share price for Avecho Biotechnology Limited (AVE:ASX) is AUD$0.00.
4
What is the dividend yield for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
5
What was Avecho Biotechnology Limited (AVE:ASX) last dividend payment?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
6
What is the franking level for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) has a franking level of 0.00%.
7
In which sector is Avecho Biotechnology Limited (AVE:ASX) classified?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) is classified in the Healthcare.